Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aba4627
PubMed Identifier: 34261798
Publication URI: http://europepmc.org/abstract/MED/34261798
Type: Journal Article/Review
Volume: 13
Parent Publication: Science translational medicine
Issue: 602
ISSN: 1946-6234